Massive 75,000-Patient registry aims to unlock best uses of proton therapy
NCT ID NCT02436941
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This registry follows up to 75,000 cancer patients treated with proton or standard X-ray radiation at Loma Linda University Medical Center, some since 1990. The goal is to track long-term outcomes like disease-free survival and local recurrence to learn which radiation approaches work best for different cancers. Participants must have a diagnosis treatable by radiation and provide consent.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Proton or photon radiation therapy
- What this could lead to
- If successful, this registry could help doctors understand which types of radiation work best for different cancers, improving future treatment decisions.
- What could go wrong
- This is an observational registry, not a treatment trial. It collects data from past and current patients, so it cannot prove new treatments or directly benefit participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 75,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2003
- Expected to finish
-
Oct 2050
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Any patients who have proton or conventional x-ray therapy
- Ages
-
Up to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of benign or malignant tumors or other conditions deemed treatable by proton or conventional photon radiotherapy * Willingness to sign an Informed Consent Document Exclusion Criteria: * There are no specific exclusion criteria, but patients who are unwilling to sign the ICD will not be included
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Benign tumor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can colorectal surgery patients go home in two days?
- Can a personal navigator help young cancer patients through treatment?
- Can a smartwatch predict which cancer patients return to hospital?
- Two-Drug combo aims to stall advanced breast cancer
- Blood thinner flush could boost tumor biopsy success
- Could a frailty score predict which older cancer patients survive intensive care?